Search

everythinglearnresearchcommunity

for

Search:↓

Using 5α-reductase inhibitors for hair loss can cause lasting sexual, physical, mental, and vascular health issues in men, even after stopping the medication.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Testosterone replacement therapy should be used for men with low testosterone levels and symptoms of hypogonadism, after careful diagnosis and considering individual needs.

Ovarian Leydig cell tumors are hard to diagnose with just advanced imaging; expert ultrasound and clinical evaluation are essential.

Low-dose ethinyl estradiol and LNG-IUD are safer contraception options for obese women with PCOS.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Hormonal therapies are safe and effective for treating adult women's acne.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Most hair loss can be diagnosed with patient history and physical exam, and a few common types make up most cases.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Various treatments exist for hair loss, but more research is needed for better options.

Hirsutism causes significant psychological distress in women.

Early diagnosis and treatment of PCOS in teenagers can help prevent more severe adult PCOS.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.